High Throughput Membrane-Water Partition Coefficients

高通量膜-水分配系数

基本信息

项目摘要

DESCRIPTION (provided by applicant): A key molecular property used for drug screening and design is the partition coefficient, measured by partitioning between an organic solvent and water, but more commonly calculated with algorithms based on octanol:water-derived hydrophobicity constants. However, it is the membrane:water partition coefficient that is more relevant to partitioning of drugs into cell membranes. In this project we propose to exploit Fluorosome Technology to efficiently determine true membrane:water partition coefficients of drugs. "Fluorosomes-intra" are fluorescently labeled membrane lipid bilayer vesicles that measure drug entry rates into the membrane. By varying the concentrations of both test drug and lipid bilayer, and analysis of data by equilibrium or kinetic algorithms, we will establish a simple, rapid partition coefficient assay with membranes containing lipids that exist in cell membranes. The assay will .be applicable to a wide range of molecules using standard spectrofluorimeters, and can be adapted to multiwell plate formats and robotics. The specific aims are: to develop the Fluorosome-intra assay conditions and mathematical data analysis methods for the measurement of membrane:water partition coefficients of drugs; to optimize the Fluorosome-intra technique for the routine measurement of membrane:water partition coefficients, and; to validate the results of Fluorosome-intra in comparison with published values of membrane:water partition coefficients of known drugs. We will acquire partition coefficients of an expanded set of test drugs with Fluorosome-intra for comparison and correlation with published results obtained by other techniques. Fluorosome-intra methodology has the capacity to greatly enhance our ability to determine and understand the partitioning of drugs and other small molecules between water and biomembranes. This project seeks to exploit features of the technique that will extend the tools available to the medicinal chemist and drug discovery scientist, and to take advantage of the high-throughput capacity of the technique. The implementation of the Fluorosome Technique to the acquisition of membrane:water partition coefficients will thus greatly facilitate drug discovery.
描述(由申请人提供):用于药物筛查和设计的关键分子特性是分配系数,通过在有机溶剂和水之间进行分配来测量,但更常见地使用基于辛醇的算法计算出来:水源性的疏水性常数。但是,是膜:水分系数与将药物分配到细胞膜中更相关。在这个项目中,我们建议利用荧光体技术有效确定真实膜:药物的水分系数。 “荧光体 - 内部”是荧光标记的膜脂质双层囊泡,可测量进入膜的药物进入速率。通过改变测试药物和脂质双层的浓度,以及通过平衡或动力学算法对数据进行分析,我们将使用含有细胞膜中存在的脂质的膜的简单快速分配系数测定。该测定法将使用标准谱荧光仪适用于各种分子,并且可以适用于多韦尔板格式和机器人技术。具体目的是:开发荧光体内部测定条件和膜测量的数学数据分析方法:药物的水分分配系数;为了优化膜体的荧光体 - 内置技术,以进行膜的常规测量:水分配系数,并且;与已知药物的水分配系数相比,验证荧光体内在的结果。我们将获取具有荧光体内置的一组扩展的测试药物组的分区系数,以比较和相关性与其他技术获得的已发表结果。荧光体内在方法论能够极大地增强我们确定和理解水与生物膜之间的药物和其他小分子分配的能力。该项目旨在利用该技术的特征,以扩展医疗化学家和药物发现科学家可用的工具,并利用该技术的高通量能力。荧光体技术的实施以获取膜:水分配系数将极大地促进药物发现。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

George E Wright的其他基金

Analogs of GTP as novel inhibitors of bacterial c-di-GMP-synthesizing enzymes
GTP 类似物作为细菌 c-di-GMP 合成酶的新型抑制剂
  • 批准号:
    8002599
    8002599
  • 财政年份:
    2010
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
Hybrid Molecules Designed to Enhance Antibiotic Activity
旨在增强抗生素活性的混合分子
  • 批准号:
    7846583
    7846583
  • 财政年份:
    2009
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
Hybrid Molecules Designed to Enhance Antibiotic Activity
旨在增强抗生素活性的混合分子
  • 批准号:
    7408526
    7408526
  • 财政年份:
    2006
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
Hybrid Molecules Designed to Enhance Antibiotic Activity
旨在增强抗生素活性的混合分子
  • 批准号:
    7054025
    7054025
  • 财政年份:
    2006
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
Hybrid Molecules Designed to Enhance Antibiotic Activity
旨在增强抗生素活性的混合分子
  • 批准号:
    7225517
    7225517
  • 财政年份:
    2006
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
Antiviral Drugs for Treatment of Herpes B Infections
用于治疗 B 型疱疹感染的抗病毒药物
  • 批准号:
    6646073
    6646073
  • 财政年份:
    2003
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
Preclinical development of a novel antibacterial for Clostridium difficile diseas
一种针对艰难梭菌疾病的新型抗菌药物的临床前开发
  • 批准号:
    8230714
    8230714
  • 财政年份:
    2002
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
DNA Polymerase IIIE, A New Antibiotic Target
DNA 聚合酶 IIIE,新的抗生素靶点
  • 批准号:
    6548864
    6548864
  • 财政年份:
    2002
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
Preclinical development of a novel antibacterial for Clostridium difficile diseas
一种针对艰难梭菌疾病的新型抗菌药物的临床前开发
  • 批准号:
    8044832
    8044832
  • 财政年份:
    2002
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
Preclinical development of a novel antibacterial for Clostridium difficile diseas
一种针对艰难梭菌疾病的新型抗菌药物的临床前开发
  • 批准号:
    7909681
    7909681
  • 财政年份:
    2002
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:

相似海外基金

Investigating KCNQ1 Mistrafficking in Long QT Syndrome
调查长 QT 综合征中 KCNQ1 的错误贩卖
  • 批准号:
    10678328
    10678328
  • 财政年份:
    2023
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
New tools for studying receptor dimers
研究受体二聚体的新工具
  • 批准号:
    10430478
    10430478
  • 财政年份:
    2022
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
Ultra-High-Throughput Plate Reader for Drug Discovery Using All-Optical Electrophysiology
使用全光学电生理学进行药物发现的超高通量读板机
  • 批准号:
    10704010
    10704010
  • 财政年份:
    2022
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
Ultra-high-throughput plate reader for drug discovery using all-optical electrophysiology
利用全光学电生理学进行药物发现的超高通量读板机
  • 批准号:
    10385256
    10385256
  • 财政年份:
    2022
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别:
New Tools for Studying Receptor Dimers
研究受体二聚体的新工具
  • 批准号:
    10579320
    10579320
  • 财政年份:
    2022
  • 资助金额:
    $ 25.54万
    $ 25.54万
  • 项目类别: